KATHLEEN PARKS: Open Payments
NPI 1457625097 · FOLEY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$842 in 37 payments from 11 companies in 2025. Trend: 2023 $747 · 2024 $671 · 2025 $842
Food & beverage: $842
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $180 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $128 |
| Novo Nordisk Inc | 6 | $98 |
| Paratek Pharmaceuticals, Inc. | 4 | $85 |
| Amgen Inc. | 4 | $68 |
| Lilly USA, LLC | 3 | $66 |
| Viatris Specialty LLC | 3 | $64 |
| Novartis Pharmaceuticals Corporation | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| Lundbeck LLC | 1 | $28 |
Products named: OFEV, Kerendia, NUZYRA, MOUNJARO, Wegovy, YUPELRI, LEQVIO, REPATHA.
Industry payments across AL — which companies pay providers there.
